Postnatal Stress Induced by Injection with Valproate Leads to Developing Emotional Disorders Along with Molecular and

Chih-Yen Wang1, Chien-Wen Cheng1, Wei-Hua Wang1

  • 1Institute of Life Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan.

Molecular Neurobiology
|December 15, 2015
PubMed

Insights

Early life stress, simulated by valproic acid (VPA) in rat pups, disrupts brain development, leading to anxiety, depression, and social deficits. These effects highlight early stress as a risk factor for emotional disorders.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Psychiatry

Background:

  • Adverse early-life experiences can significantly impact brain development and increase the risk of psychiatric disorders.
  • Understanding the specific mechanisms linking early-life stress to behavioral outcomes is crucial for developing effective interventions.

Purpose of the Study:

  • To investigate the effects of a single early-life stressor, valproic acid (VPA) administration, on neurodevelopment and behavior in a rat model.
  • To explore the molecular and cellular changes in the brain following VPA exposure during a critical developmental window.

Main Methods:

  • Valproic acid (VPA), a histone deacetylation inhibitor (HDACi), was administered intraperitoneally to male rat pups at postnatal day 7 (P7).
  • Gene expression (DCX, NeuroD1), cell proliferation, neuronal populations (DCX+, NeuN+), and microglial morphology were assessed in the hippocampus and amygdala.
  • Behavioral tests were conducted at later postnatal ages to evaluate anxiety-like, depressive-like, and social interaction behaviors.

Main Results:

  • VPA injection downregulated neuronal differentiation genes (DCX, NeuroD1) and decreased neuronal populations in the hippocampus and dentate gyrus.
  • Increased cell proliferation was observed in the dentate gyrus and amygdala, alongside rapid microglial morphological changes.
  • VPA-treated rats exhibited depressive-like and anxiety-like behaviors, along with impaired social interaction at 8 weeks of age.

Conclusions:

  • A single VPA administration during early development disrupts neural differentiation, alters neuron-glia interactions, and induces long-lasting behavioral deficits.
  • Early-life stress, even a single exposure, poses a significant risk for developing emotional and social disorders, potentially due to persistent molecular and cellular alterations.
  • Findings underscore the critical role of the early-life environment in shaping brain development and long-term mental health outcomes.